|
|
Volumn 59, Issue 6, 2000, Pages 404-406
|
|
Anti-TNFα: A new dimension in the pharmacotherapy of the spondyloarthropathies!?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
INFLIXIMAB;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ALPHA;
ANTIRHEUMATIC AGENT;
MONOCLONAL ANTIBODY;
ANKYLOSING SPONDYLITIS;
DISEASE SEVERITY;
HUMAN;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RESPIRATORY TRACT INFECTION;
SHORT SURVEY;
SPONDYLOARTHROPATHY;
ACUTE DISEASE;
IMMUNOLOGY;
NOTE;
PATIENT SELECTION;
ACUTE DISEASE;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, PSORIATIC;
HUMANS;
PATIENT SELECTION;
SPONDYLITIS, ANKYLOSING;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0033625713
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.59.6.404 Document Type: Short Survey |
|
Times cited : (40)
|
|
References (38)
|
